"in conjunction with Coramsine to achieve the spectacular success against mesothelioma in the recent mouse tests"
Mesothelioma was always the original target - a) seemed to work? and b) had fast track advantages as no alternative existed.
Any ideas why this strategy has been ditched - doesn't work as well as expected or is it more effective against the new melanoma target????
cheers, ob2
SBP
solbec pharmaceuticals limited
"in conjunction with Coramsine to achieve the spectacular...
Add to My Watchlist
What is My Watchlist?